SynthesisFrontiers in immunology2025
Effects of different exercise prescription parameters on metabolic and inflammatory biomarkers in cancer patients: a systematic review, meta-analysis, and meta-regression.
Synthesis in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Comparative efficacy of exercise modes on inflammatory cytokines in patients with breast cancer: a systematic review with pairwise and network meta-analyses.Scientific reports · 2026Pooled it
- Optimized exercise prescription for alleviating cancer-related fatigue in breast cancer survivors after primary treatment: a systematic review and dose-response network meta-analysis.Frontiers in public health · 2026Pooled it
- Modality-specific effects of structured exercise on immunometabolic biomarkers in postmenopausal obesity: a Bayesian network meta-analysis.Frontiers in immunology · 2026Pooled it
- Effects of exercise on angiogenesis biomarkers in cancer patients: a systematic review and meta-analysis.Frontiers in immunology · 2025Pooled it
- MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms.Blood advances · 2026Trial
- Blueprint for adapting the cardiac rehabilitation model for oncology patients with cardiovascular-kidney-metabolic syndrome.American journal of preventive cardiology · 2026Article
- Spirulina and exercise: a two-pronged approach to mitigating oxidative stress in colorectal cancer.Molecular biology reports · 2025Review
- Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines.Biomolecules · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to systematically evaluate the effects of exercise interventions on metabolic and inflammatory biomarkers in cancer patients, and to identify potential dose-response relationships and modulatory mechanisms using Robust Variance Estimation (RVE) and MetaForest models. Methods: A systematic search of five databases was conducted from inception to March 6, 2025, based on the PICOS framework. Randomized controlled trials involving exercise interventions of ≥4 weeks in adults (≥18 years) with cancer were included. Effect sizes were pooled using RVE to estimate overall intervention effects. Risk of bias was assessed using the ROB2 tool, and the certainty of evidence was evaluated with the GRADE approach. Univariable RVE meta-regression was performed to examine the linear effects of each moderator. MetaForest was used to assess variable importance and to explore potential nonlinear relationships between moderators and intervention effects. Subgroup analyses were conducted by cancer type and intervention timing. Results: A total of 83 eligible articles were included, representing 74 distinct randomized controlled trials, from which data were extracted. Exercise significantly reduced insulin levels (ES = -0.24, SE = 0.08, p < 0.01, I² = 49%), representing a small but meaningful effect. TNF-α showed a small effect (ES = -0.22, SE = 0.13) but was not statistically significant (p = 0.10, I² = 74%). MetaForest modeling revealed that the most favorable changes in IL-6, adiponectin, and IGF-1 were associated with high-intensity aerobic exercise; TNF-α, IL-8, and IL-10 responded best to longer weekly exercise duration; and improvements in glucose, leptin, and CRP were most pronounced when exercise was combined with caloric restriction. Conclusion: Regular exercise confers modest but favorable effects on metabolic and inflammatory biomarkers in cancer patients. Meta-regression highlighted the importance of high-intensity aerobic exercise (HRR > 85%) in modulating IL-6, adiponectin, and IGF-1, as well as longer weekly exercise duration (>280 min/week) in improving TNF-α and IL-8. Mechanistically, high-intensity aerobic exercise may serve as a primary trigger for activating pathways that mediate metabolic and inflammatory improvements. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251002676.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.